SCHEMBL17870935

SCHEMBL17870935

O=CC1(C(F)(F)F)CCCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9446535 0.97
SCHEMBL16125265 0.94
SCHEMBL568854 0.88
SCHEMBL13463040 0.72
SCHEMBL24424003 0.72 KDM4E (0.30)
SCHEMBL19458428 0.70
SCHEMBL6839667 0.67
SCHEMBL23812100 0.64
SCHEMBL3806113 0.62
SCHEMBL979571 0.61

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110769853-B Treatment of male aging 北京生命科学研究所 2022-06-03 CN claimed
CN-110769853-A Treatment of male aging 北京生命科学研究所 2020-02-07 CN claimed
CN-117320754-A Prostatitis treatment 北京生命科学研究所 2023-12-29 CN disclosed
CN-110769853-B Treatment of male aging 北京生命科学研究所 2022-06-03 CN disclosed
EP-3802500-A1 MELANOCORTIN SUBTYPE-2 RECEPTOR (MC2R) ANTAGONISTS AND USES THEREOF Crinetics Pharmaceuticals, Inc. (US) 2021-04-14 EP disclosed
CN-107108492-B Cell necrosis inhibitor 北京生命科学研究所 2021-03-19 CN disclosed
CN-110769853-A Treatment of male aging 北京生命科学研究所 2020-02-07 CN disclosed
EP-3224245-A1 NECROSIS INHIBITORS National Institute Of Biological Sciences, Beijing (CN) 2017-10-04 EP disclosed
WO-2016101887-A1 NECROSIS INHIBITORS NATIONAL INSTITUTE OF BIOLOGICAL SCIENCES, BEIJING (CN) 2016-06-30 WO disclosed
CN-104364246-A Piperidine derivatives useful as GPR119 agonists TOYOTA MOTOR CO LTD 2015-02-18 CN disclosed